Member Info for EarlofAim

Thanks Chesh,

but the question is how to I give my findings on other companies?

I mean the next big riser?

any idea

Won't see another He1 style volume of on AIM for a while, I'm saying with conviction,

however could we see another 1000% riser, yes we will,

just have to look for it.

the next 10 bagger won't need to trade 50,000 times, but could get to 10 bagger in 3000 trades.

keep finding the next multi bagger

Thanks ria,

let me know if you find any more baggers

I actually bought after Monday morning rns, most was busy with HE1 And I managed to load up without market makers moving the price.

then sat on it quitely.

I honestly can't believe sp ran so quickly in the morning.

GLA and Dyor before its too,

another one if FAB

AI - Artificial intelligence

ML - Machine Learning

world class for antibodies

OptiMAL® research programme. As our industry rapidly turns to find new ways to hasten the discovery of better bio-therapeutics to take to the clinic, we anticipate deploying these capabilities to ensure Fusion is at the forefront of Antibody discovery and development process including those using AI/ML."

Got abused by bunsenburner123.....

Profits gone to FAB

reckon FAB has news coming, Ai ML big business

There Ai tech clearly works for antibody discovery

The global monoclonal antibody therapeutics market was valued at $186 billion in 2021 and is forecast to surpass $445 billion in 2028

Here's the link

https://www.linkedin.com/posts/adrian-kinkaid-4067395_join-us-in-welcoming-our-new-team-members-activity-7161293963084120064-JVht?utm_source=share&utm_medium=member_ios

Reason for sp dropping from yesterday 34p is sellers around.

yesterday was good trade opp

going to wait till seller is out and buy back.

guys buy the potentials like I posted on SND, that's done well

just need FAB, still to make a move.

join me on FAB, Ai ML are big business

Then we have the likes of AstraZeneca and GSK interested in the platform of AI ML

FAB has the world best platform

28 November 2023

Fusion Antibodies plc

("Fusion" or the "Company")

OptiMAL® collaboration agreement

Fusion Antibodies plc (AIM: FAB), specialists in pre-clinical antibody discovery, engineering and supply for both therapeutic drug and diagnostic applications, announces that it has signed a collaboration agreement (the "Agreement") with the National Cancer Institute ("NCI") for the use of OptiMAL® in the discovery of novel antibodies against targets selected by NCI.

Under the terms of the Agreement, Fusion will provide access to the OptiMAL® technology to NCI for deployment against an agreed number of targets, being primarily cancer targets, over a period of up to two years, in order to develop potential therapeutic antibodies against the selected targets. The parties will work together to ensure successful validation of the OptiMAL® technology and jointly publish any results from the collaboration. The validation will be run at NCI's laboratories by their staff and antibodies identified pursuant to the Agreement would be retained by NCI.

NCI, part of the US National Institutes of Health, is the US federal government's principal agency for cancer research and training.

Demand increasing,

So the hired 4 new members, well done CEO

rns would be nice

Interesting trades

10.03 £9934 bought at 5.5p

sells at 10.26 for £10640

looks like sellers out for good......

move up now.....

Market Makers missing FAB CEO comments CEO said "optimal© the best in the class, nothing comes close to this tech"

FAB Ai antibody discovery will be huge! Market set to grow to $4.9 Billion! Fab are 1 deal away with a big pharama for a significant re-rate

Mms will have to let this go soon

Ceo posting on LinkedIn, should also Rns IMO

I'm confident AI ML will get AstraZeneca or GSK interested.

both are shown to be investing over £400m in AI ML and tech.

Fusion Antibodies fab has world class platform in optimal®

markets yet to value Optimal®

Yes SND done well today

mms had no choice but to let it go

I posted on Monday, no one was interested, in fact got lots of abuse from Bunsenburner123

next mega rise could be coming from #fab

worth a look,

still under the radar and undervalued company

Fab fusionantibodies.com

Ceo posted new recruits on LinkedIn

AstraZeneca and GSK interested in AI ML, those are FAB specialists in, world class According to CEO

.... FAB could get either GSK or AstraZeneca as partners

Fab CEO posted on LinkedIn

here's the link

https://www.linkedin.com/posts/adrian-kinkaid-4067395_join-us-in-welcoming-our-new-team-members-activity-7161293963084120064-JVht?utm_source=share&utm_medium=member_ios

CEO said "optimal© the best in the class, nothing comes close to this tech"

FAB Ai antibody discovery will be huge! Market set to grow to $4.9 Billion! Fab are 1 deal away with a big pharama for a significant re-rate

won't suprise to rns on AstraZeneca to take interest in FAB

Both AstraZeneca and GSK trying to find AI and ml platform

however FAB has Optimal® the best in the world.

world class

not long before AstraZeneca or GSK makes a move